W C Eckelman

发表

An automated radiopharmaceutical dispenser.

P S Plascjak, K Kim, W Meyer, 1997, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Instant 99m compounds.

P Richards, W C Eckelman, 1971, Nuclear-Medizin.

High resolution PET, SPECT and projection imaging in small animals.

W C Eckelman, J J Vaquero, M V Green, 2001, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.

Radiopharmaceutical quality assurance--pilot study.

W C Eckelman, N E Herrara, W Hauser, 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy

W C Eckelman, W H Theodore, R E Carson, 2003, Neurology.

Kinetic Modeling of [11C]Raclopride: Combined PET-Microdialysis Studies

W C Eckelman, R E Carson, R. Saunders, 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Development of fluorine-18-labeled 5-HT1A antagonists.

W C Eckelman, R E Carson, E Jagoda, 1999, Journal of medicinal chemistry.

Radiosynthesis of [18F]3-acetylcyclofoxy: a high affinity opiate antagonist.

W C Eckelman, T R Burke, T. Burke, 1985, The International journal of applied radiation and isotopes.

Opioid receptor imaging with positron emission tomography and [(18)F]cyclofoxy in long-term, methadone-treated former heroin addicts.

W C Eckelman, R E Carson, P. Herscovitch, 2000, The Journal of pharmacology and experimental therapeutics.

Using single photon emission tomography (SPECT) and positron emission tomography (PET) to trace the distribution of muscarinic acetylcholine receptor (MACHR) binding radioligands.

W C Eckelman, R E Carson, P. Herscovitch, 1999, Life sciences.

Kinetic Analysis of the 5-HT2A Ligand [11C]MDL 100,907

W C Eckelman, R E Carson, H Watabe, 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Biodistribution and catabolism of Ga-67-labeled anti-Tac dsFv fragment.

W C Eckelman, E Jagoda, I. Pastan, 1997, Bioconjugate chemistry.

S‐[18F]Acetylcyclofoxy: a useful probe for the visualization of opiate receptors in living animals

W C Eckelman, S M Larson, T R Burke, 1984, FEBS letters.

Synthesis and evaluation of (17 alpha,20E)-21-[125I]iodo-19-norpregna-1,3,5(10),20-tetraene-3,17 -diol and (17 alpha,20E)-21-[125I]iodo-11 beta-methoxy-19-norpregna-1,3,5(10),20-tetraene-3,17-diol (17 alpha-(iodovinyl)estradiol derivatives) as high specific activity potential radiopharmaceuticals.

W C Eckelman, R E Gibson, R C Reba, 1984, Journal of medicinal chemistry.

Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture.

W C Eckelman, E Jagoda, W. Eckelman, 1999, Cancer research.

Quantification of Amphetamine-Induced Changes in [11C]Raclopride Binding with Continuous Infusion

W C Eckelman, R E Carson, R. Saunders, 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Receptor-binding radiotracers: a class of potential radiopharmaceuticals.

W C Eckelman, R E Gibson, R C Reba, 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Device-dependent activity estimation and decay correction of radionuclide mixtures with application to Tc-94m PET studies.

P S Plascjak, W C Eckelman, R E Carson, 2001, Medical physics.

Pharmacokinetic analysis of blood distribution of intravenously administered 153Gd-labeled Gd(DTPA)2- and 99mTc(DTPA) in rats.

W C Eckelman, D. Covell, P. Wedeking, 1990, Magnetic resonance imaging.

A neutral technetium-99m complex for myocardial imaging.

W C Eckelman, P. Wedeking, A. Nunn, 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Sensitivity of new radiopharmaceuticals.

W C Eckelman, W. Eckelman, 1998, Nuclear medicine and biology.

Direct labeling with 99mTc.

W C Eckelman, W. Eckelman, J Steigman, 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Experiment assessment of mass effects in the rat: implications for small animal PET imaging.

W C Eckelman, J J Vaquero, J Seidel, 2004, Nuclear medicine and biology.

[I-125] 17 alpha-Iodovinyl 11 beta-methoxyestradiol: in vivo and in vitro properties of a high-affinity estrogen-receptor radiopharmaceutical.

W C Eckelman, R E Gibson, R C Reba, 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Measurement of dopamine release with continuous infusion of [11C]raclopride: optimization and signal-to-noise considerations.

W C Eckelman, R E Carson, H Watabe, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Quantitative analysis of tumor biochemisty using PET and SPECT.

W C Eckelman, B. Croft, K. Kurdziel, 2000, Nuclear medicine and biology.

PET evaluation of [(18)F]FCWAY, an analog of the 5-HT(1A) receptor antagonist, WAY-100635.

W C Eckelman, R E Carson, H Watabe, 2000, Nuclear medicine and biology.

Fluoro analogs of WAY-100635 with varying pharmacokinetics properties.

W C Eckelman, E Jagoda, W. Eckelman, 2000, Nuclear medicine and biology.

Muscarinic Cholinergic Receptor Measurements with [18F]FP-TZTP: Control and Competition Studies

W C Eckelman, R E Carson, E Jagoda, 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Liquid chromatography-tandem mass spectrometry identification of metabolites of two 5-HT1A antagonists, N-[2-[4-(2-methoxylphenyl)piperazino]ethyl]-N-(2-pyridyl) trans- and cis-4-fluorocyclohexanecarboxamide, produced by human and rat hepatocytes.

M Der, W C Eckelman, E Jagoda, 2001, Journal of chromatography. B, Biomedical sciences and applications.